Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Impact of infectious complications on outcomes after allogeneic hematopoietic stem cell transplantation in elderly patients: A geth-TC study

Blood (2025) 146 (Supplement 1): 6039.

https://doi.org/10.1182/blood-2025-6039

Published: 2025

Journal Articles

Operational cure in patients with newly diagnosed multiple myeloma after autologous stem cell transplantation: Long-term survivors and impact of induction regimens.

Jose Miguel Mateos Perez, Francesc Fernández-Avilés, Maria Teresa Cibeira López, Maria Carmen Martinez Munoz, Carlos Fernandez de Larrea, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Maria Suarez-Lledo, Maria Queralt Salas Gay, David Moreno, Aina Oliver-Caldes, Alberto Lazaro García, Montserrat Rovira, Joan Batista Blade Creixenti, Laura Rosiñol Dachs

Blood (2025) 146 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2025-5776

Published: 2025

Journal Articles

Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients

Blood (2025) 146 (Supplement 1): 2652.

https://doi.org/10.1182/blood-2025-2652

Published: 2025

Journal Articles

Donor age matters: Selecting 10/10 muds under 35 enhances survival after ptcy allo-HCT

Blood (2025) 146 (Supplement 1): 7825.

https://doi.org/10.1182/blood-2025-7825

Published: 2025

Journal Articles

Frailty as a prognostic factor in younger adult patients with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation

Sergio Rodriguez-Rodriguez, Nihar Desai, Maria Queralt Salas Gay, Eshrak Al-Shaibani, Igor Novitzky-Basso, Arjun Law, Auro Viswabandya, Fotios Michelis, Jonas Mattsson, Dennis Kim, Rajat Kumar, Tommy Alfaro Moya

Blood (2025) 146 (Supplement 1): 4430.

https://doi.org/10.1182/blood-2025-4430

Published: 2025

Journal Articles

Easix, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura

Blood (2025) 146 (Supplement 1): 6661.

https://doi.org/10.1182/blood-2025-6661

Published: 2025

Journal Articles

Younger donors, better outcomes: The impact of donor age in haploidentical transplantation for acute myeloid leukemia. study conducted on behalf of geth-TC

Blood (2025) 146 (Supplement 1): 6070.

https://doi.org/10.1182/blood-2025-6070

Published: 2025

Journal Articles

Monocytosis as prognostic factor for chronic graft versus host disease

Cristina Marrero-Cepeda, Teresa Caballero-Velazquez, Francisco Manuel Martin-Dominguez, Nancy Rodriguez-Torres, Cristina Blazquez Go I, Maria Carmen Martinez Munoz, Maria Queralt Salas Gay, Maria Suarez-Lledo, Francesc Fernández-Avilés, Montserrat Rovira, Carlos Solano, Ariadna Perez-Martinez, Jose Piñana, Ana Belén Bocanegra, Joud Zanabili, Maite Zudaire, José Antonio Pérez-Simón

Blood (2025) 146 (Supplement 1): 7760.

https://doi.org/10.1182/blood-2025-7760

Published: 2025

Journal Articles

M-Easix (Better Than EASIX) Correlates with Specific Endotheliopathy Biomarkers, Predicts Severe CAR-T Cell Toxicities and Discriminates from Sepsis

Blood (2024) 144 (Supplement 1): 3423.

https://doi.org/10.1182/blood-2024-208083

Published: 2024

Journal Articles

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Alberto Mussetti, MD, Maria Queralt Salas Gay, MD, Maria Condom, MD, Maite Antonio, MD PhD, Cristian Ochoa, Iulia Ivan, David Jiménez Ruiz De La Torre, MD, Gabriela Isabel Sanz-Linares, MD, Belen Ansoleaga, Rocio Parody, MD, Ali Bazarbachi, MD PhD, Anna Sureda Balari, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138780

Published: 2020

Journal Articles

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Anti-Thymocyte Globulin As Graft Versus Host Disease Prophylaxis

Queralt Salas Gay, MD, Arjun Law, MDDM, Wilson Lam, MD, Zeyad Al-Shaibani, MD, Fotios V. Michelis, MD PhD, Santhosh Thyagu, MDDM, Dennis Dong Hwan Kim, MD PhD, Jeff H. Lipton, MD PhD, Rajat Kumar, MD, Auro Viswabandya, MDDM

Blood (2018) 132 (Supplement 1): 2103.

https://doi.org/10.1182/blood-2018-99-119417

Published: 2018

Journal Articles

High Incidence but Very Low Mortality of Epstein Barr Virus Related Post-Transplantation Lymphoproliferative Disorder after T-Cell Replete Haploidentical Peripheral Blood Stem Cell Transplantation

Queralt Salas Gay, MD, Zeyad Al-Shaibani, MD, Wilson Lam, MD, Fotios V. Michelis, MD PhD, Santhosh Thyagu, MDDM, Dennis Dong Hwan Kim, MD PhD, Jeff H. Lipton, MD PhD, Rajat Kumar, MD, Auro Viswabandya, MDDM, Arjun Law, MDDM

Blood (2018) 132 (Supplement 1): 2104.

https://doi.org/10.1182/blood-2018-99-119162

Published: 2018

Journal Articles

Combination of ATG and Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Peripheral Blood Stem Cell Transplants for High-Risk Hematological Malignancies- a Single Centre Experience

Shruti Prem Sudha, MD DM, Eshetu G Atenafu, M.Sc., P.Stat, Queralt Salas Gay, MD, Zoe Evans, Zeyad Al-Shaibani, MD, David Loach, MD, Arjun Law, MDDM, Wilson Lam, MD, Santhosh Thyagu, MD DM, Fotios V. Michelis, MD PhD, Dennis Dong Hwan Kim, MD PhD, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Auro Viswabandya, MD DM

Blood (2018) 132 (Supplement 1): 4569.

https://doi.org/10.1182/blood-2018-99-111955

Published: 2018

Journal Articles

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Maria Queralt Salas Gay, MD, Santiago Mercadal, MD, Eva Domingo Domenech, MD, Ana C Oliveira, MD PhD, Maite Encuentra, Fina Climent, MD PhD, Cristina Baca Cano, MD, Marcio Andrade-Campos, MD PhD, Esmeralda De la Banda, MD, Carmen Aguilera, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, Eva González-Barca, MD PhD

Blood (2017) 130 (Supplement 1): 4151.

https://doi.org/10.1182/blood.V130.Suppl_1.4151.4151

Published: 2017

Journal Articles

Long-Term Follow-up of a Prospective Phase II Trial of Extended Treatment with Rituximab in Patients with B-Cell Post-Transplant Lymphoproliferative Disease and Comparison with a Cohort of Patients Treated in Real Life. Analysis on Behalf of the Spanish Lymphoma Group (GELTAMO)

Eva Gonzalez-Barca, MD PhD, Maria Queralt Salas Gay, MD, Francisco Javier Capote Huelva, Jose Gomez Codina, Carlos Panizo, MD PhD, Antonio Salar, MD PhD, Eva Domingo Domenech, MD, Alicia Bailen, Josep-Maria Ribera, MD, Andres Lopez, Javier Briones, MD, Andres Muñoz, Maite Encuentra, Alberto Fernandez de Sevilla, MD PhD

Blood (2017) 130 (Supplement 1): 1545.

https://doi.org/10.1182/blood.V130.Suppl_1.1545.1545

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Impact of infectious complications on outcomes after allogeneic hematopoietic stem cell transplantation in elderly patients: A geth-TC study

Operational cure in patients with newly diagnosed multiple myeloma after autologous stem cell transplantation: Long-term survivors and impact of induction regimens.

Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients

Donor age matters: Selecting 10/10 muds under 35 enhances survival after ptcy allo-HCT

Frailty as a prognostic factor in younger adult patients with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation

Easix, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura

Younger donors, better outcomes: The impact of donor age in haploidentical transplantation for acute myeloid leukemia. study conducted on behalf of geth-TC

Monocytosis as prognostic factor for chronic graft versus host disease

M-Easix (Better Than EASIX) Correlates with Specific Endotheliopathy Biomarkers, Predicts Severe CAR-T Cell Toxicities and Discriminates from Sepsis

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Anti-Thymocyte Globulin As Graft Versus Host Disease Prophylaxis

High Incidence but Very Low Mortality of Epstein Barr Virus Related Post-Transplantation Lymphoproliferative Disorder after T-Cell Replete Haploidentical Peripheral Blood Stem Cell Transplantation

Combination of ATG and Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Peripheral Blood Stem Cell Transplants for High-Risk Hematological Malignancies- a Single Centre Experience

Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution

Long-Term Follow-up of a Prospective Phase II Trial of Extended Treatment with Rituximab in Patients with B-Cell Post-Transplant Lymphoproliferative Disease and Comparison with a Cohort of Patients Treated in Real Life. Analysis on Behalf of the Spanish Lymphoma Group (GELTAMO)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only